Data Sheet 1_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.pdf

Data Sheet 1_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.pdf

Introduction<p>Genetic polymorphisms in CYP2D6 and CYP2C19 significantly influence the metabolism, efficacy, and safety of antidepressant medications. Limited data exist on the prevalence of these actionable pharmacogenetic variants in the Central Indian population. This study aimed to determi...

Saved in:

書目詳細資料
主要作者:	Santenna Chenchula (14775163) (author)
其他作者:	Atal Shubham (22679330) (author), Rozatkar Abhijit (22679333) (author), Tamonud Modak (22679336) (author), Kohat Komal (22679339) (author), Ratinder Jhaj (22679342) (author), Singh Jitendra (22679345) (author), Satyaprakash V. (22679348) (author), Sadasivam Balakrishnan (22679351) (author)
出版:	2025
主題:	Pharmacology pharmacogenetics CYP2D6 CYP2C19 antidepressants common mental disorders indian population copy number variation CPIC
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Image 2_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.tif
由: Santenna Chenchula (14775163)
出版: (2025)

Image 1_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.tif
由: Santenna Chenchula (14775163)
出版: (2025)

Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review
由: Emytis Tavakoli (14127837)
出版: (2025)

Image 1_Evaluation of the relationship between cytochrome P450 (CYP) 1A2 gene copy number variation and CYP1A2 protein content and enzyme activity in canine liver.jpeg
由: Francisco Gonzales Zamora (21761210)
出版: (2025)

Table 1_Evaluation of the relationship between cytochrome P450 (CYP) 1A2 gene copy number variation and CYP1A2 protein content and enzyme activity in canine liver.docx
由: Francisco Gonzales Zamora (21761210)
出版: (2025)

Data Sheet 1_StarTRAC-CYP2D6: a method for CYP2D6 allele-specific copy number determination using digital PCR.pdf
由: Wendy Y. Wang (5030501)
出版: (2025)

Sequence analysis of gorilla CYP4B1.
由: Saskia Hüsken (21616072)
出版: (2025)

Functional analysis of primate CYP4B1 orthologs.
由: Saskia Hüsken (21616072)
出版: (2025)

Oligonucleotides designed for sequencing CYP4B1 orthologs from apes, introducing amino acid changes, and establishing CYP4B1-EGFP fusion proteins.
由: Saskia Hüsken (21616072)
出版: (2025)

Expression analysis of recombinant purified CYP4B1 enzymes.
由: Saskia Hüsken (21616072)
出版: (2025)

Artificial engineering of a full-length gorilla CYP4B1.
由: Saskia Hüsken (21616072)
出版: (2025)

Table 1_Polymorphisms in CYP3A5, CYP3A4, and ABCB1 genes: implications for calcineurin inhibitors therapy in hematopoietic cell transplantation recipients—a systematic review.docx
由: Luiz Carlos da Costa-Junior (21727631)
出版: (2025)

Functional analysis of mutated CYP4B1 enzymes in HepG2 cells.
由: Saskia Hüsken (21616072)
出版: (2025)

Systematic analysis of the activity of different CYP4B1 orthologs during primate evolution.
由: Saskia Hüsken (21616072)
出版: (2025)

Functional consequences of the four critical amino acid substitutions in Homo sapiens and rabbit CYP4B1.
由: Saskia Hüsken (21616072)
出版: (2025)

Activity, expression and localization of CYP4B1-EGFP fusion proteins in HuH-7 cells.
由: Saskia Hüsken (21616072)
出版: (2025)

Clinical trials in depression: Integrated collection across EU and US registries
由: Kate Stewart (21786413)
出版: (2025)

Image 1_Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder.tiff
由: Daniel Hain (234962)
出版: (2025)

Active Site Residues Contribute to the Multistep Dynamics of Dicyclotyrosine Bound to CYP121A1 of Mycobacterium tuberculosis
由: Patil Pranita Uttamrao (22474784)
出版: (2025)

Association between different CYP2R1, CYP27B1, CYP24A1, and DBP SNPs genotypes and the clinical characteristics of multiple sclerosis.
由: Laith AL-Eitan (6841382)
出版: (2025)

<i>In silico</i> modeling of potential key amino acid positions for the functional activity of mammalian CYP4B1.
由: Saskia Hüsken (21616072)
出版: (2025)

PTable S4 Expression validation of CYP1B1.
由: Li-Hong Chen (610826)
出版: (2025)

CYP2R1, CYP27B1, CYP24A1, and <i>DBP</i> (GC) SNPs, their minor allele frequencies, and HWE p-value in cases and controls.
由: Laith AL-Eitan (6841382)
出版: (2025)

Validation of CYP1B1 expression in THP-1 monocytes.
由: Li-Hong Chen (610826)
出版: (2025)

Analysis on ArcDFI’s Compound-CYP Interaction Block for drug-food compound pair Midazolam and Berberine.
由: Mogan Gim (22439477)
出版: (2025)

Analysis on ArcDFI’s Compound-CYP Interaction Block for drug-food compound pair Sulfonylurea and Salicylate.
由: Mogan Gim (22439477)
出版: (2025)

CYP gene expression of indoxyl sulfate (IS) in primary human hepatocytes.
由: Masao Togao (21696599)
出版: (2025)

Genetic models and distributions of SNPs within (<i>CYP2R1, CYP27B1, CYP24A1,</i> and <i>DBP</i>) genes in 192 cases and 196 controls.
由: Laith AL-Eitan (6841382)
出版: (2025)

Restoring the activity of gibbon and two great ape CYP4B1 orthologs by p.C106R and p.H244R substitution.
由: Saskia Hüsken (21616072)
出版: (2025)

Knockdown of CYP1B1 inhibited monocytes activation and tryptophan metabolism.
由: Li-Hong Chen (610826)
出版: (2025)

The transfection efficiency of CYP1B1 knockdown in THP-1 cells.
由: Li-Hong Chen (610826)
出版: (2025)

Identification of tryptophan metabolism-related gene CYP1B1 in sepsis.
由: Li-Hong Chen (610826)
出版: (2025)

CYP3A activity in primary human hepatocytes treated with indoxyl sulfate (IS).
由: Masao Togao (21696599)
出版: (2025)

CYP3A activity in DPX-2 cells treated with each test compound.
由: Masao Togao (21696599)
出版: (2025)

Image 1_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
由: Qianqian Du (5773832)
出版: (2025)

Image 3_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
由: Qianqian Du (5773832)
出版: (2025)

Image 2_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
由: Qianqian Du (5773832)
出版: (2025)

Image 4_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
由: Qianqian Du (5773832)
出版: (2025)

Image 5_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
由: Qianqian Du (5773832)
出版: (2025)

Image 8_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.png
由: Qianqian Du (5773832)
出版: (2025)